Cargando…

Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population

POLE/POLD1 gene variants have been suggested as potential markers for immunotherapy due to their significant association with the tumor mutational burden (TMB), an effective indicator for response prediction in immunotherapy. However, the correlation of POLE/POLD1 variants with MSI, MMR, TMB, MMR-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jianfei, Gong, Yuan, Zhao, Wei, Han, Zhifeng, Guo, Shaohua, Liu, Hongyi, Peng, Xiumei, Xiao, Wenhua, Li, Yuemin, Dang, Shiying, Liu, Guifeng, Li, Lifeng, Huang, Tanxiao, Chen, Shifu, Song, Lele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823448/ https://www.ncbi.nlm.nih.gov/pubmed/31673068 http://dx.doi.org/10.1038/s41598-019-52414-z

Ejemplares similares

POLE/POLD1 mutation and tumor immunotherapy
por: Ma, Xiaoting, et al.
Publicado: (2022)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Role of POLE and POLD1 in familial cancer
por: Mur, Pilar, et al.
Publicado: (2020)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1
por: Mur, Pilar, et al.
Publicado: (2023)

Integrating POLE / POLD1 mutated for immunotherapy treatment planning of advanced stage non‐small cell lung cancer
por: Zheng, Shuhua, et al.
Publicado: (2023)

Risk of colorectal cancer for carriers of a germline mutation in POLE or POLD1
por: Buchanan, Daniel D., et al.
Publicado: (2017)

Detection of Allelic Variants of The POLE and POLD1 Genes in Colorectal Cancer Patients
por: Pätzold, LA, et al.
Publicado: (2017)

POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer
por: Siraj, Abdul K, et al.
Publicado: (2020)

Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
por: Yao, Jianfei, et al.
Publicado: (2022)

Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
por: Palles, Claire, et al.
Publicado: (2012)

Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps
por: Elsayed, Fadwa A., et al.
Publicado: (2019)

POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer
por: Esteban-Jurado, Clara, et al.
Publicado: (2017)

Roles of human POLD1 and POLD3 in genome stability
por: Tumini, Emanuela, et al.
Publicado: (2016)

Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers
por: Jansen, Anne ML, et al.
Publicado: (2016)

Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region
por: Siraj, Abdul K., et al.
Publicado: (2019)

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
por: Chen, Yan‐Xing, et al.
Publicado: (2021)

Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families
por: Weber, Christine A. M., et al.
Publicado: (2023)

The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
por: Song, Lele, et al.
Publicado: (2017)

Non-Exonuclease Domain POLE Mutations Associated with Immunotherapy Benefit
por: Dong, Sharlene, et al.
Publicado: (2022)

POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East
por: Siraj, Abdul K., et al.
Publicado: (2020)

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor
por: He, Junjun, et al.
Publicado: (2021)

Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade
por: Liu, Xiaoliang, et al.
Publicado: (2019)

A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
por: Tang, Hui, et al.
Publicado: (2022)

POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance
por: Bellido, Fernando, et al.
Publicado: (2016)

Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review
por: Li, Xiaobin, et al.
Publicado: (2020)

CTCF Mediates Replicative Senescence Through POLD1
por: Hou, Yuli, et al.
Publicado: (2021)

Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis
por: Peng, Honghua, et al.
Publicado: (2021)

Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort
por: Khan, Nikhat, et al.
Publicado: (2017)

Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers
por: Song, Lele, et al.
Publicado: (2020)

Prospects of POLD1 in Human Cancers: A Review
por: Gola, Michał, et al.
Publicado: (2023)

ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC
por: Chen, Yao, et al.
Publicado: (2020)

Elevated expression of POLD1 is associated with poor prognosis in breast cancer
por: Qin, Qinghong, et al.
Publicado: (2018)

Human POLD1 modulates cell cycle progression and DNA damage repair
por: Song, Jing, et al.
Publicado: (2015)

E2F1 mediates the downregulation of POLD1 in replicative senescence
por: Gao, Shichao, et al.
Publicado: (2019)

Rapid genome editing by CRISPR-Cas9-POLD3 fusion
por: Reint, Ganna, et al.
Publicado: (2021)

Disease progression and pseudoprogression following partial response with rare gingiva metastasis upon IBI308 (sintilimab) immunotherapy reflects the complexity of metastatic lung cancer: a case report
por: Jiang, Haiping, et al.
Publicado: (2021)

Scrutinizing Deleterious Nonsynonymous SNPs and Their Effect on Human POLD1 Gene
por: Bappy, Md. Nazmul Islam, et al.
Publicado: (2022)

Pold3 is required for genomic stability and telomere integrity in embryonic stem cells and meiosis
por: Zhou, Zhongcheng, et al.
Publicado: (2018)

Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC
por: He, Yayi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bvlqhh7p56q72ba4odd0jegcka